1 completed, 1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Acute Intracranial Hemorrhage: new trials by email Literature Review of Acute Intracranial Hemorrhage trials Research Report on Acute Intracranial Hemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of pRehospital Intervention With trAditional Chinese Medicine for Acute strokE Xingnaojing injection within 24 hours of symptom onset - Stroke, Acute Ischemic Stroke | Unknown | Dongzhimen Hospital, Beijing | 1000 | 2020-03-20 | 2020-06-11 | |
| Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor andexanet alfa, Usual Care - Acute Intracranial Hemorrhage | Phase 4 | Completed | Alexion Pharmaceuticals, Inc. | 530 | 2019-06-06 | 2024-07-03 |
Ischemic Stroke (1) · Stroke (1) · Thrombosis (1)
Cardiovascular Diseases (2) · Vascular Diseases (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Embolism and Thrombosis (1) · Nervous System Diseases (1)
PRT064445 (1)
Alexion Pharmaceuticals, Inc. (1) · Dongzhimen Hospital, Beijing (1)
Austria (1) · Belgium (1) · Canada (1) · China (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Israel (1) · Italy (1) · Latvia (1) · Lithuania (1)
Ying Gao, MD (1)
PMID 36105230, PMID 38264861, PMID 38749032, PMID 39167819, PMID 40289797, PMID 42093656, PMID 42656564
2018 (1)